日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

STAG2 regulates interferon signaling in melanoma via enhancer loop reprogramming

STAG2通过增强子环重编程调控黑色素瘤中的干扰素信号传导

Zhaowei Chu # ,Lei Gu # ,Yeguang Hu # ,Xiaoyang Zhang # ,Man Li ,Jiajia Chen ,Da Teng ,Man Huang ,Che-Hung Shen ,Li Cai ,Toshimi Yoshida ,Yifeng Qi ,Zhixin Niu ,Austin Feng ,Songmei Geng ,Dennie T Frederick ,Emma Specht ,Adriano Piris ,Ryan J Sullivan ,Keith T Flaherty ,Genevieve M Boland ,Katia Georgopoulos ,David Liu ,Yang Shi ,Bin Zheng

Clinical and molecular characterization of virus-positive and virus-negative Merkel cell carcinoma

病毒阳性和病毒阴性默克尔细胞癌的临床和分子特征

Gabriel J Starrett, Manisha Thakuria, Tianqi Chen, Christina Marcelus, Jingwei Cheng, Jason Nomburg, Aaron R Thorner, Michael K Slevin, Winslow Powers, Robert T Burns, Caitlin Perry, Adriano Piris, Frank C Kuo, Guilherme Rabinowits, Anita Giobbie-Hurder, Laura E MacConaill, James A DeCaprio3

Toward Minimal Residual Disease-Directed Therapy in Melanoma

迈向黑色素瘤的微小残留病灶导向治疗

Florian Rambow, Aljosja Rogiers, Oskar Marin-Bejar, Sara Aibar, Julia Femel, Michael Dewaele, Panagiotis Karras, Daniel Brown, Young Hwan Chang, Maria Debiec-Rychter, Carmen Adriaens, Enrico Radaelli, Pascal Wolter, Oliver Bechter, Reinhard Dummer, Mitchell Levesque, Adriano Piris, Dennie T Frederic

Ex Vivo Profiling of PD-1 Blockade Using Organotypic Tumor Spheroids

利用类器官肿瘤球体进行PD-1阻断的体外分析

Russell W Jenkins,Amir R Aref,Patrick H Lizotte,Elena Ivanova,Susanna Stinson,Chensheng W Zhou,Michaela Bowden,Jiehui Deng,Hongye Liu ,Diana Miao,Meng Xiao He ,William Walker,Gao Zhang,Tian Tian,Chaoran Cheng,Zhi Wei,Sangeetha Palakurthi,Mark Bittinger,Hans Vitzthum,Jong Wook Kim,Ashley Merlino,Max Quinn,Chandrasekar Venkataramani,Joshua A Kaplan,Andrew Portell,Prafulla C Gokhale,Bart Phillips,Alicia Smart,Asaf Rotem,Robert E Jones,Lauren Keogh,Maria Anguiano,Lance Stapleton,Zhiheng Jia,Michal Barzily-Rokni,Israel Cañadas,Tran C Thai,Marc R Hammond,Raven Vlahos,Eric S Wang,Hua Zhang,Shuai Li,Glenn J Hanna,Wei Huang,Mai P Hoang,Adriano Piris,Jean-Pierre Eliane,Anat O Stemmer-Rachamimov,Lisa Cameron,Mei-Ju Su,Parin Shah,Benjamin Izar,Manisha Thakuria,Nicole R LeBoeuf,Guilherme Rabinowits,Viswanath Gunda,Sareh Parangi,James M Cleary,Brian C Miller,Shunsuke Kitajima,Rohit Thummalapalli,Benchun Miao,Thanh U Barbie,Vivek Sivathanu,Joshua Wong,William G Richards , Raphael Bueno , Charles H Yoon,Juan Miret,Meenhard Herlyn,Levi A Garraway,Eliezer M Van Allen,Gordon J Freeman,Paul T Kirschmeier,Jochen H Lorch,Patrick A Ott,F Stephen Hodi,Keith T Flaherty,Roger D Kamm  ,Genevieve M Boland,Kwok-Kin Wong,David Dornan , Cloud Peter Paweletz ,David A Barbie

Loss of cohesin complex components STAG2 or STAG3 confers resistance to BRAF inhibition in melanoma

黏连蛋白复合物成分 STAG2 或 STAG3 的缺失导致黑色素瘤对 BRAF 抑制产生抗性

Che-Hung Shen, Sun Hye Kim, Sebastian Trousil, Dennie T Frederick, Adriano Piris, Ping Yuan, Li Cai, Lei Gu, Man Li, Jung Hyun Lee, Devarati Mitra, David E Fisher, Ryan J Sullivan, Keith T Flaherty, Bin Zheng

Downregulation of the Ubiquitin Ligase RNF125 Underlies Resistance of Melanoma Cells to BRAF Inhibitors via JAK1 Deregulation

泛素连接酶 RNF125 的下调通过 JAK1 失调导致黑色素瘤细胞对 BRAF 抑制剂产生耐药性

Hyungsoo Kim, Dennie T Frederick, Mitchell P Levesque, Zachary A Cooper, Yongmei Feng, Clemens Krepler, Laurence Brill, Yardena Samuels, Nicholas K Hayward, Ally Perlina, Adriano Piris, Tongwu Zhang, Ruth Halaban, Meenhard M Herlyn, Kevin M Brown, Jennifer A Wargo, Reinhard Dummer, Keith T Flaherty,

Landscape of Targeted Anti-Cancer Drug Synergies in Melanoma Identifies a Novel BRAF-VEGFR/PDGFR Combination Treatment

黑色素瘤靶向抗癌药物协同作用概况确定了一种新型 BRAF-VEGFR/PDGFR 联合治疗方法

Adam A Friedman, Arnaud Amzallag, Iulian Pruteanu-Malinici, Subash Baniya, Zachary A Cooper, Adriano Piris, Leeza Hargreaves, Vivien Igras, Dennie T Frederick, Donald P Lawrence, Daniel A Haber, Keith T Flaherty, Jennifer A Wargo, Sridhar Ramaswamy, Cyril H Benes, David E Fisher

A melanoma cell state distinction influences sensitivity to MAPK pathway inhibitors

黑色素瘤细胞状态差异影响对 MAPK 通路抑制剂的敏感性

David J Konieczkowski, Cory M Johannessen, Omar Abudayyeh, Jong Wook Kim, Zachary A Cooper, Adriano Piris, Dennie T Frederick, Michal Barzily-Rokni, Ravid Straussman, Rizwan Haq, David E Fisher, Jill P Mesirov, William C Hahn, Keith T Flaherty, Jennifer A Wargo, Pablo Tamayo, Levi A Garraway

Response to BRAF inhibition in melanoma is enhanced when combined with immune checkpoint blockade

与免疫检查点阻断相结合可增强黑色素瘤对 BRAF 抑制的反应

Zachary A Cooper, Vikram R Juneja, Peter T Sage, Dennie T Frederick, Adriano Piris, Devarati Mitra, Jennifer A Lo, F Stephen Hodi, Gordon J Freeman, Marcus W Bosenberg, Martin McMahon, Keith T Flaherty, David E Fisher, Arlene H Sharpe, Jennifer A Wargo

TORC1 suppression predicts responsiveness to RAF and MEK inhibition in BRAF-mutant melanoma

TORC1抑制可预测BRAF突变型黑色素瘤对RAF和MEK抑制剂的反应性

Ryan B Corcoran,Stephen Michael Rothenberg, Aaron N Hata, Anthony C Faber, Adriano Piris, Rosalynn M Nazarian, Ronald D Brown, Jason T Godfrey, Daniel Winokur, John Walsh, Mari Mino-Kenudson, Shyamala Maheswaran, Jeffrey Settleman, Jennifer A Wargo, Keith T Flaherty, Daniel A Haber, Jeffrey A Engelman